STOKStoke Therapeutics, Inc.
What is the market doing?
The market is leaning against it: in a downtrend (−20% vs 200-day) and a crowded short (+18% of shares).
In a downtrend, below its 50- and 200-day averages. Price is −20% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
A crowded short, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How STOK is trading
Stoke Therapeutics, Inc. is −27% over the past year while the S&P 500 is +16%: 43 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −20%
vs 200-day average · a clear downtrend
- RSI (14)
- 48
RSI (14) · neutral
- Below its 52-week high
- 35%
Below its 52-week high
Details›
- Last close2026-10-23
- $25.01
- 1 monthS&P 500 −0.94%
- −1.0%
- 1 yearS&P 500 +16%
- −27%
- 5 yearsS&P 500 +86%
- +8.4%
- vs 50-day average$27.99
- −11%
- 52-week high
- $38.35
- 52-week low
- $22.37
- Annualised volatility
- 64%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $647K
| Year | Return |
|---|---|
| 2026 (year to date) | −21% |
| 2025 | +188% |
| 2024 | +110% |
| 2023 | −43% |
| 2022 | −62% |
| 2021 | −61% |
| 2020 | +119% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 2 of 7 | −3.4% |
| Feb | 7 | 3 of 7 | +3.9% |
| Mar | 7 | 2 of 7 | +1.1% |
| Apr | 7 | 3 of 7 | −3.0% |
| May | 7 | 4 of 7 | +13% |
| Jun | 7 | 3 of 7 | −1.1% |
| Jul | 8 | 4 of 8 | −4.6% |
| Aug | 8 | 5 of 8 | +13% |
| Sep | 8 | 2 of 8 | −11% |
| Oct | 8 | 5 of 8 | +9.1% |
| Nov | 7 | 3 of 7 | −2.5% |
| Dec | 7 | 5 of 7 | +12% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.